U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110051) titled 'Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient' on July 31.
Brief Summary: In current study we aim to compare between nalbuphine versus tramal for post-operative pain control in abdominal surgeries in pediatric.
Study Start Date: Jan. 15
Study Type: INTERVENTIONAL
Condition:
Tramadol
Nalbuphine
Abdominal Surgeries
Pediatric Cancer
Intervention:
DRUG: Nalbuphine
this group will a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)
DRUG: Tramadol
this group will receive a single dose of tra...